SPARSENTAN AS FIRST-LINE TREATMENT OF INCIDENT PATIENTS WITH IgA NEPHROPATHY: PRELIMINARY FINDINGS FROM THE SPARTAN TRIAL

  Back

14 Apr 2024 5:45 p.m. 6:45 p.m.

WCN24-AB-773, Poster Board= SUN-042

Chee Kay Cheung Poster Presenter